CRH slips 3.3% as investors appear to keep weighing Arcosa deal financing

CRH plc (CRH) is down 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver looks to be continued investor caution around CRH’s large pending Arcosa acquisition and the financing tied to it, rather than a fresh deterioration in the company’s operating results. The company’s latest quarterly update was strong and kept full-year guidance unchanged, so today’s decline appears more consistent with deal-related digestion and valuation pressure than with a new earnings miss.

Details:

CRH’s latest posted quarterly release showed second-quarter revenue, profit, and margins all rose from a year earlier, and management reaffirmed full-year 2026 guidance.

CRH also highlighted its agreement to buy Arcosa for $8.5 billion, a deal that would further expand its North America aggregates and infrastructure footprint.

A July SEC filing showed CRH put in place a new three-year $2.5 billion term loan facility and still expects to use bridge financing and other funding sources before the merger closes.

With no new company press release visible after the late-July results update, this could be because traders are reassessing balance-sheet risk, financing costs, and integration execution on CRH’s largest current transaction.

Sources:

CRH, SEC, Arcosa

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRH Insider Trading Activity

$CRH insiders have traded $CRH stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CRH stock by insiders over the last 6 months:

RICHARD H FEARON purchased 3,800 shares for an estimated $397,062
SIOBHAN TALBOT purchased 2,000 shares for an estimated $204,223
PADRAIG ORIORDAIN (See Remarks) sold 1,492 shares for an estimated $155,831

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CRH Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CRH Hedge Fund Activity

We have seen 533 institutional investors add shares of $CRH stock to their portfolio, and 505 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

BAILLIE GIFFORD & CO added 5,994,407 shares (+1177683.1%) to their portfolio in Q2 2026, for an estimated $641,401,549
BOSTON PARTNERS added 3,911,823 shares (+43.4%) to their portfolio in Q2 2026, for an estimated $418,565,061
VICTORY CAPITAL MANAGEMENT INC added 3,894,931 shares (+1747.1%) to their portfolio in Q2 2026, for an estimated $416,757,617
STATE STREET CORP added 3,167,104 shares (+12.5%) to their portfolio in Q2 2026, for an estimated $338,880,128
JPMORGAN CHASE & CO added 2,932,221 shares (+inf%) to their portfolio in Q2 2026, for an estimated $313,747,647
ALPHINITY INVESTMENT MANAGEMENT PTY LTD removed 2,669,224 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $285,606,968
BANK OF NEW YORK MELLON CORP added 2,564,362 shares (+30.8%) to their portfolio in Q2 2026, for an estimated $274,386,734

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRH Price Targets

Multiple analysts have issued price targets for $CRH recently. We have seen 4 analysts offer price targets for $CRH in the last 6 months, with a median target of $140.5.

Here are some recent targets:

Timna Tanners from Wells Fargo set a target price of $132.0 on 07/08/2026
Justin Jordan from Jefferies set a target price of $165.6 on 06/26/2026
Adrian Huerta from JP Morgan set a target price of $140.0 on 03/03/2026
Cedar Ekblom from Morgan Stanley set a target price of $141.0 on 03/02/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.